CORVEL CORPORATION vs WILLIS TOWERS WATSON PLC, two Insurance Brokers stocks. A side-by-side on valuation, growth, margins, returns, and what each price is betting.
Two firms that sell expertise rather than capital, at very different scales. Willis Towers Watson brokers insurance and advises on benefits across a $25.5B business; CorVel manages workers-comp and health-services claims from a far smaller base. On the numbers that line up, Willis reads as the established earner: a 20.68% return on equity, a 16.84% net margin, and a 6.15% free-cash yield. CorVel trades at 29.42 times earnings, nearly double Willis's 15.59, which points to a market paying up for the smaller firm's growth path. Willis sits at 3.16 times book and carries debt of 0.78 times equity, and pays a 1.39% dividend. A steady global advisor against a niche claims processor the market pays up for.
Comparison updated 2026-07-11.
| Metric | CRVL | WTW |
|---|---|---|
| Price | $62.50 | $289.63 |
| Market cap | $3.2B | $27.8B |
| Sector | Financial Services | Financial Services |
| Stage | Mature | Mature |
| P/E | 29.2 | 17.0 |
| P/B | 8.18 | 3.45 |
| P/S | 3.36 | 2.81 |
| EV/EBITDA | 94.2 | 14.0 |
| Revenue growth | +7.1% | +1.3% |
| Gross margin | 25.4% | — |
| Operating margin | — | 18.6% |
| Net margin | 11.5% | 16.8% |
| Return on equity | 28.0% | 20.7% |
| Return on assets | 17.2% | 5.6% |
| Dividend yield | — | 1.3% |
| Debt / equity | 0.00 | 0.78 |
| Current ratio | 2.03 | 1.19 |
| Piotroski F (quality) | 7 / 9 | 4 / 9 |
Each week boothcheck ranks the stocks whose prices are betting on the most. Read the most stretched bets archive →
boothcheck is also on Android. Get the app on Google Play →
The stronger value is highlighted per metric where one is strictly better on that single number; it is not an overall verdict on either company. For informational and research purposes only. Not investment advice. Not a recommendation to buy, sell, or hold any security. boothcheck is not a registered investment adviser. Past performance does not guarantee future results.